HUP0300937A3 - Novel polymorphic form of 17-betha-(n-ter. butyl carbamoyl)-4-aza-5alpha-androst-1-en-3-one and process for preparing it - Google Patents

Novel polymorphic form of 17-betha-(n-ter. butyl carbamoyl)-4-aza-5alpha-androst-1-en-3-one and process for preparing it

Info

Publication number
HUP0300937A3
HUP0300937A3 HU0300937A HUP0300937A HUP0300937A3 HU P0300937 A3 HUP0300937 A3 HU P0300937A3 HU 0300937 A HU0300937 A HU 0300937A HU P0300937 A HUP0300937 A HU P0300937A HU P0300937 A3 HUP0300937 A3 HU P0300937A3
Authority
HU
Hungary
Prior art keywords
betha
5alpha
androst
aza
ter
Prior art date
Application number
HU0300937A
Other languages
Hungarian (hu)
Original Assignee
Reddys Lab Ltd Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr filed Critical Reddys Lab Ltd Dr
Publication of HUP0300937A2 publication Critical patent/HUP0300937A2/en
Publication of HUP0300937A3 publication Critical patent/HUP0300937A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0300937A 2000-09-07 2001-06-19 Novel polymorphic form of 17-betha-(n-ter. butyl carbamoyl)-4-aza-5alpha-androst-1-en-3-one and process for preparing it HUP0300937A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN737DE2000 2000-09-07
PCT/US2001/019546 WO2002020553A1 (en) 2000-09-07 2001-06-19 NOVEL POLYMORPHIC FORM OF 17-β-(N-TER.BUTYL CARBAMOYL)-4-AZA-5-α-ANDROST-1-EN-3-ONE AND A PROCESS FOR PREPARING IT

Publications (2)

Publication Number Publication Date
HUP0300937A2 HUP0300937A2 (en) 2007-02-28
HUP0300937A3 true HUP0300937A3 (en) 2007-10-29

Family

ID=11097081

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300937A HUP0300937A3 (en) 2000-09-07 2001-06-19 Novel polymorphic form of 17-betha-(n-ter. butyl carbamoyl)-4-aza-5alpha-androst-1-en-3-one and process for preparing it

Country Status (12)

Country Link
EP (1) EP1322663A1 (en)
JP (1) JP2004508380A (en)
AU (1) AU6991101A (en)
BR (1) BR0113732A (en)
CA (1) CA2422159A1 (en)
HU (1) HUP0300937A3 (en)
IL (1) IL154785A0 (en)
NO (1) NO20031045L (en)
NZ (1) NZ525116A (en)
PL (1) PL361014A1 (en)
WO (1) WO2002020553A1 (en)
ZA (1) ZA200302554B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2206065B1 (en) * 2002-10-31 2005-08-16 Ragactives, S.L. PROCEDURE FOR OBTAINING THE POLYMORPHIC FORM I OF FINASTERIDA.
EP1651661B1 (en) * 2003-07-03 2008-08-27 Cipla Ltd. Process for the preparation of finasteride form i
CN1294913C (en) * 2004-12-23 2007-01-17 鲁南制药集团股份有限公司 Medication combination of containing finasteride and cyclodextrin or ramification

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225100A (en) * 1987-06-29 1991-09-25 Merck & Co Inc Reaction of steroids (including 4-azasteroids) with a silylating agent in the presence of a quinone to introduce a delta' double bond and silylated intermediates
US5237061A (en) * 1988-10-31 1993-08-17 Merck & Co., Inc. Methods of synthesizing benign prostatic hypertropic agents and their intermediates
US5021575A (en) * 1989-11-13 1991-06-04 Merck & Co., Inc. Method for introducing a 1,2 double bond into azasteroids
US5091534A (en) * 1990-08-27 1992-02-25 Merck & Co., Inc. Trialkylsilyl trifluoromethanesulfonate mediated α-methylenic carbon functionalization of 4-AZA-5α-androstan-3-one steroids
US5468860A (en) * 1992-11-19 1995-11-21 Merck & Co., Inc. New finasteride processes

Also Published As

Publication number Publication date
HUP0300937A2 (en) 2007-02-28
NO20031045L (en) 2003-04-29
NZ525116A (en) 2004-11-26
AU6991101A (en) 2002-03-22
EP1322663A1 (en) 2003-07-02
NO20031045D0 (en) 2003-03-06
CA2422159A1 (en) 2002-03-14
ZA200302554B (en) 2004-02-19
WO2002020553A1 (en) 2002-03-14
IL154785A0 (en) 2003-10-31
PL361014A1 (en) 2004-09-20
BR0113732A (en) 2003-07-29
JP2004508380A (en) 2004-03-18

Similar Documents

Publication Publication Date Title
AP2003002757A0 (en) Process and intermediates for preparing anticancer compounds
MXPA03000585A (en) Fermentation process for the preparation of l-threonine.
ZA200108623B (en) Process for preparing imidachloprid.
ZA200109476B (en) Process for the adaptation of flavor mixtures.
HUP0301649A3 (en) Process for preparing azacycloalkanoylaminothiazoles
AUPR503101A0 (en) Improved leaching process
MXPA03002464A (en) Process for the preparation of benzotriazoles.
HUP0300937A2 (en) Novel polymorphic form of 17-betha-(n-ter. butyl carbamoyl)-4-aza-5alpha-androst-1-en-3-one and process for preparing it
AU2001263777A1 (en) Redeposition or backstain inhibition during stonewashing process
AU2002222604A1 (en) Process for preparing substance GM-95
AU2001266689A1 (en) 4-benzyl-2-hydroxy-1,4-oxazin-3-one and polymorphic forms thereof
AU2001280244A1 (en) Novel process for preparing 3-aminomethyl-4-z-methoxyiminopyrrolidine
MXPA03009210A (en) New process for the preparation of oxabispidines.
ZA200202504B (en) Process for making wine.
EP1295864A4 (en) Process for preparation of 1,5-diaminonaphthalenes
GB0021066D0 (en) Novel process
AU2001281892A1 (en) Process for preparing flavour compounds
AU2001272549A1 (en) Extraction process
HU0204443D0 (en) Process for preparing fluoroformates
GB0021342D0 (en) Improved Process
HK1031881A1 (en) Process for preparing 8-cyclopentyl-6-ethyl-3-Äsu bstitutedÜ-5,8-dihydro-4H-1,2,3A, 7,8-pentaaza-as-indacenes and intermediates useful therein.
GB0013487D0 (en) Novel process
AU2001230250A1 (en) Method for synthesizing 2,2,4,4-tetrasubstituted 1,3,5-cyclohexane trions
AU2001261564A1 (en) Process for preparing cis-aminochromanols
AU2002221114A1 (en) Novel ss-lactam compounds and process for preparing the same